AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.54+0.18 (+0.78%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.54+0.18 (+0.78%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|
13.9 C
New York
Tuesday, November 17, 2026

Energy

November Journal of Cardiac Failure Focus Issue on Artificial Intelligence: AI Echo Raises HFpEF Detection to 78%

The November Journal of Cardiac Failure focus issue on artificial intelligence in heart failure also features a large language model study of why patients with heart failure go without...

Alpha Aesthetics Partners Launches Practice Aesthetics, a First-of-Its-Kind Clinical Education Platform

BOSTON, Nov. 17, 2026 /PRNewswire/ -- Alpha Aesthetics Partners ("Alpha"), a leading medical aesthetics...

RushDATA™ Enables Wet-Lab Validation of AI-Designed Antibodies Generated by Molence Bio’s Mol-1

CAMBRIDGE, Mass., Nov. 13, 2026 /PRNewswire/ -- Biointron Biological USA Inc. ("Biointron") is pleased...

CIBC Named One of Canada’s Top 100 Employers for 15th Straight Year

TORONTO, Nov. 17, 2026 /CNW/ -- CIBC is pleased to announce its recognition as...

ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026

SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ --  ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for...

California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue “Reinvesting” In Vietnam

David Duong supports environmental education for young people in Vietnam while workers at Vietnam Waste Solutions get a free health check-up, in keeping with...

Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep

Preclinical study shows 1.5- to 2-hour increase in total sleep time as Company advances toward clinical development and attracts Chris Brearley, M.D., as Chief...

Ascletis’ Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

- With first patient dosed in Phase III clinical trial, Ascletis' strategic partner Sagimet Biosciences Inc. ("Sagimet") advances denifanstat (ASC40)'s U.S. registrational program, building...

Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects

SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a...

Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects

SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a...

Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects

SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a...

HUYABIO International Announces HBI-8000 and Nivolumab Combination Reduces the Risk of Disease Progression by 27% in Patients with Advanced Melanoma in Phase 3 Trial

Oral HBI-8000 plus intravenous nivolumab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared with nivolumab alone, reducing the risk of...

California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue “Reinvesting” In Vietnam

David Duong supports environmental education for young people in Vietnam while workers at Vietnam Waste Solutions get a free health check-up, in keeping with...

Centrus to Webcast Conference Call on November 5 at 8:30 a.m. ET

BETHESDA, Md., Oct. 22, 2026 /PRNewswire/ -- Centrus Energy Corp. (NYSE: LEU) will broadcast its quarterly conference call with shareholders and the financial community...

Southwest Gas Holdings, Inc. to Report Third Quarter 2026 Results on November 4, 2026

Company to Host Earnings Conference Call on November 4, 2026LAS VEGAS, Oct. 22, 2026 /PRNewswire/ -- Southwest Gas Holdings, Inc. (NYSE: SWX) ("Southwest Gas...

Joint Statement between the Minister of Energy and Natural Resources of Canada and the Minister of Energy and Natural Resources of Türkiye on Cooperation...

ANKARA, Türkiye, Oct. 22, 2026 /CNW/ -- On October 22, 2026, Canada's Minister of Energy and Natural Resources Tim Hodgson and Türkiye's Minister of...

Air Products Declares Quarterly Dividend

LEHIGH VALLEY, Pa., Oct. 22, 2026 /PRNewswire/ -- The Board of Directors of Air Products (NYSE:APD) today declared a quarterly dividend of $1.81 per...

Vector Science and Therapeutics Corp. Responds to HHS Secretary Kennedy’s Call for a Regulated Peptide Marketplace

Vector's cGMP-manufactured Rx peptides, independently tested and Rx-labeled for physician use, are built to the standards of safety, quality and inspected manufacturing that the...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.